Get access to Peak’s hand-selected opportunities for superior returns.


We co-invest alongside you.

Markets change, economies evolve and industries are being disrupted by new and innovative ways of doing business. This change creates opportunity. Opportunity that Peak clients capitalise on through our hand-selected corporate deals.

We only recommend opportunities to you that our investment team personally invests in.


Peak Opportunity Fund investors receive preferential allocations each hand-selected corporate deal.

Peak was lead manager for LSH which develops and commercialises medical diagnostic and monitoring technology to instantly diagnose, monitor and manage chronic diseases & skin diseases using your smartphone.
Peak investors entered at a Pre-IPO price of $0.10 and an IPO price of $0.20. LSH closed on day 1 at $0.40 on volume of ~6.4m shares.
Expert360 operates an online global platform that connects industry experts and customers to market their skills, knowledge, and expertise.
Expert360 is a privately held company. Peak raised $1m+ via a global venture capital investor.
MPL provides private health insurance and health solutions in Australia and New Zealand, including hospital insurance, as well as life, travel, and pet insurance services. Peak investors entered at $2.00. MPL reached a day 1 high of $2.20+ or 10%+ returns.
CFO produces next generation carbon products, designed to meet growing demand for ultra-high performance engineering materials in the military, industrial, aerospace, and commercial product markets.
Peak investors entered at the IPO price of $0.20, closing on Day 1 at $0.70 or +250%.

CM8 is an Australian technology Company focused on mobile software and services, including applications and messaging services.
Peak investors entered at $0.16, netting a return of 47%.
RAP is developing digital healthcare solutions to assist doctors and empower patients to diagnose and manage respiratory disease.
Peak investors entered at $0.20. RAP reached a high of $0.55, up 175%.

NTI is focused on the development & commercialisation of regulated medical solutions for diagnosis & treatment of neurological disorders.
Peak investors entered at the IPO price of $0.20, closing at $0.55 or + 175% within a month.
EMC specialises in developing energy-efficient wastewater treatment solutions.
Peak investors entered at the placement price of $0.64, with solid trading up to $1.09 or +70% shortly after.
FZO gives customers control over what their kids are doing online, and when and where they are doing it.
Peak Investors entered in the seed round at $0.07, before its listing at $0.20 ~3 months later and subsequent trading up to $0.35.
LPI is a diversified pure-play lithium explorer with focus on exploration of prospective lithium regions across Western Australia and South America.
Peak investors entered at the IPO price of $0.20 and has traded strongly since listing, with a high of $0.50 or +150%.
Paradigm is an Australian biopharmaceutical company focused on bone marrow edema (BME) and respiratory diseases.
PAR listed at $0.35, reaching a high of $0.62 within 12-months of listing, up +82%.
SW1 is a Digital Entertainment business that provides fully integrated solutions to the resources sector, with continued penetration of larger verticals such as the Hospitality, Lifestyle Village and Aged Care sectors.
Peak investors entered at $0.15, reaching a high of $0.25, up 67%.

“Years in the business has taught me the difference between a good and a bad advisor. The bad ones will shove deals down my throat with no analysis. Peak will analyse and recommend according to each investor’s needs. Peak’s first deal was a 35% day one profit, you can’t ask for more than that! I look forward to many more well analysed Peak deals and thank them for the work done so far!”


Sean Factor| Tempo Capital